United States · FDA National Drug Code directory
Glycopyrrolate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-744_9f8d9c4c-f326-4784-8ea4-f791613077f7
- Product NDC
- 16571-744
- Form
- TABLET
- Composition / generic term
- Glycopyrrolate
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20201006
- Source listing expiry
- 20271231
Source-listed ingredients
- GLYCOPYRROLATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 CONTAINER (16571-744-03) · 16571-744-03
- 90 TABLET in 1 CONTAINER (16571-744-09) · 16571-744-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →